New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 9, 2012
10:46 EDTCPIXCumberland falls after Wells Fargo analyst cuts rating
Drug maker Cumberland Pharmaceuticals (CPIX) is falling after Wells Fargo analyst Michael Tong downgraded the stock to Market Perform from Outperform in a note to investors earlier this morning. Another pharmaceutical company, Innopharma, has received FDA approval to market a generic version of Cumberland's Acetadopte, a treatment for chronic pulmonary disease and acute bronchopulmonary disease, the analyst wrote. Tong doesn't know when Innopharma will begin marketing its drug, and he believes that Cumberland may seek a preliminary injunction that could postpone the launch. Still, the analyst believes that Cumebrland's stock is unlikely to appreciate as long as uncertainty about the matter persists. In mid-morning trading, Cumberland fell 27c, or 4.88%, to $5.22.
News For CPIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 23, 2015
16:08 EDTCPIXCumberland launches Caldolor in Australia
Subscribe for More Information
09:22 EDTCPIXCumberland announces approval of Caldolor injection
Cumberland announced the approval of Caldolor Injection for pediatric patients six months of age and older. The approval was based on data submitted to the U.S. Food and Drug Administration (FDA) as part of a post-marketing commitment following approval of Caldolor in adults in 2009. Caldolor is the first and only injectable non-steroidal anti-inflammatory drug approved for use in pediatric patients.
November 20, 2015
09:21 EDTCPIXCumberland announces favorable Acetadote patent ruling
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use